Bio-Medical Pharmaceutical Manufacturing Corporation

FDA inspection history in Houston, Texas, 2020 to 2026

2
Form 483s
1
Warning letter

Every document, by year

  • Warning letter
  • Form 483

2020: one Form 483; 2025: one Form 483; 2026: one warning letter.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2020One Form 483, at Houston, Texas.
  2. 2025–26One Form 483 and one warning letter, at Houston, Texas.
  3. 2025The longest 483 on file: 9 observations over 7 pages at Houston, Texas.

Cited most

Across all Bio-Medical Pharmaceutical Manufacturing observations on file

The complete Bio-Medical Pharmaceutical Manufacturing file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Documents

3 on file, newest first
DateDocumentPrice
2026-02-05Warning letter Warning letter$99
2025-08-29483 Form 483$99
2020-01-23483 Form 483$99

Investigators on these documents

Ronda R. Loyd Jones (1)Shatina R. Alridge (1)

FEI number 1650090 · most recent document Feb 5, 2026

About Bio-Medical Pharmaceutical Manufacturing Corporation

How many FDA Form 483s has Bio-Medical Pharmaceutical Manufacturing Corporation received?

FDA Intel has 2 Form 483s on file for Bio-Medical Pharmaceutical Manufacturing Corporation; the most recent is dated Aug 29, 2025.

When was Bio-Medical Pharmaceutical Manufacturing Corporation last inspected by FDA?

The most recent FDA inspection document on file for Bio-Medical Pharmaceutical Manufacturing Corporation is a Form 483 dated Aug 29, 2025, for the site in Houston, Texas.

What did FDA cite at Bio-Medical Pharmaceutical Manufacturing Corporation?

The regulations cited most in the observations on file for Bio-Medical Pharmaceutical Manufacturing Corporation are 21 CFR 211.67(a) (Equipment cleaning and maintenance), 2 times; 21 CFR 211.68(a) (Automatic, mechanical, and electronic equipment), 2 times; 21 CFR 211.113(b) (Control of microbiological contamination), 1 time.

Has Bio-Medical Pharmaceutical Manufacturing Corporation received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Bio-Medical Pharmaceutical Manufacturing Corporation; the most recent is dated Feb 5, 2026.